US EditionPublished • loading... • Updated
Jarvis: FDA’s mifepristone decision sows confusion
Summary by The Columbian
1 Articles
1 Articles
Jarvis: FDA’s mifepristone decision sows confusion
The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret the decision. Could this be a sign that the Trump administration isn’t interested in taking federal action to further restrict abortion access? Read more...
·Vancouver, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
